September 8, 2015 — Extending clot-preventing dual antiplatelet therapy (DAPT) beyond the recommended 12 months after ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
September 08, 2015
September 4, 2015 — Janssen Pharmaceuticals Inc. and its development partner Bayer HealthCare announced results from ...
September 04, 2015
September 1, 2015 — Extending treatment with the anticoagulant bivalirudin for at least four hours after completion of ...
September 01, 2015
August 26, 2014 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report ...
August 26, 2015
August 12, 2015 — The National Institute for Health and Care Excellence (NICE) has recommended a new treatment to help ...
August 12, 2015
August 5, 2015 — Boehringer Ingelheim announced the first U.S. patients have been enrolled in two of the company's ...
August 05, 2015
August 4, 2015 — Triple therapy is no better than dual antiplatelet therapy in preventing major adverse cardiac events ...
August 04, 2015
July 22, 2015 — The Medicines Company announced the U.S. Court of Appeals for the Federal Circuit Court has ruled ...
July 22, 2015
July 21, 2015 "” Two companion papers published in Academic Emergency Medicine address the question of when it is ...
July 21, 2015
July 13, 2015 - Researchers have created tiny gel particles that can perform the same essential functions as platelets ...
July 13, 2015
July 7, 2015 - Results from an interim analysis of the Phase III RE-VERSE AD patient study demonstrate that 5 g of ...
July 07, 2015
July 1, 2015 -Â The American College of Cardiology (ACC) Statin Intolerance App is now available to help guide clinicians ...
July 01, 2015
June 22, 2015 - The Medicines Company announced the approval of cangrelor (Kengreal) by the U.S. Food and Drug ...
June 22, 2015
June 18, 2015 - Atrial fibrillation patients on the anticoagulant dabigatran were more likely to adhere to the ...
June 18, 2015
June 17, 2015 - Merck announced that the New England Journal of Medicine published the results of the IMPROVE-IT trial ...
June 17, 2015© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now